Internal Medicine, Hematology & Oncology · Asheville, NC
NPI
1063402998
Since 2005
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
551 Brevard Rd
Asheville, NC, 28806
Phone (828) 212-7021
Medicare paid, 2024
$1.7M
85,200 services
Medicare patients, 2024
825
Average age 75
Drug cost, 2024
$3.8M
1,324 prescriptions
Company payments, 2024
$814
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Shantae L Lucas was code J0185 (injection, aprepitant, 1 mg), 9,360 times for 30 patients. In total Shantae L Lucas billed 85,200 services in 145 codes, and Medicare paid $1.7M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-11-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0185 Injection, aprepitant, 1 mg | Office | 9,360 | 30 | $1.34 | $13K |
| J9271 Injection, pembrolizumab, 1 mg | Office | 7,600 | 16 | $44.86 | $341K |
| J0897 Injection, denosumab, 1 mg | Office | 2,880 | 29 | $20.32 | $59K |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 2,100 | 21 | $15.57 | $33K |
| J9041 Injection, bortezomib, 0.1 mg | Office | 2,065 | 12 | $1.36 | $2,806 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,241 | 45 | $0.09 | $112 |
| 36415 Venipuncture Blood Collection | Office | 1,001 | 471 | $8.65 | $8,659 |
| 85025 Blood Count | Office | 969 | 431 | $7.61 | $7,374 |
| J0640 Injection, leucovorin calcium, per 50 mg | Office | 877 | 14 | $3.55 | $3,109 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 870 | 37 | $0.71 | $616 |
| J9190 Injection, fluorouracil, 500 mg | Office | 589 | 14 | $2.32 | $1,368 |
| 99214 Office E&M - Established | Office | 523 | 276 | $87.23 | $46K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 404 | 269 | $12.10 | $4,887 |
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 400 | 20 | $0.07 | $28.81 |
| 96413 Chemotherapy Administration | Office | 273 | 103 | $91.83 | $25K |
By year: 2022 $1.8M for 106,911 services; 2023 $1.5M for 72,511 services; 2024 $1.7M for 85,200 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,001 | 471 | $8.65 | $8,659 |
| 85025 Blood Count | 969 | 431 | $7.61 | $7,374 |
| 81002 Clinical Chemistry | 36 | 16 | $3.41 | $123 |
| 85045 Blood Count | 19 | 17 | $3.91 | $74.29 |
Medicare prescription drug claims, 2024
In 2024, the drug Shantae L Lucas prescribed most often to Medicare patients was Anastrozole, with 237 prescriptions and refills. In total Shantae L Lucas wrote 1,324 Medicare prescriptions that cost $3.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 237 | 594 | 68 | $4,123 |
| Letrozole Generic | 105 | 239 | 32 | $1,786 |
| Imbruvica Ibrutinib | 58 | 58 | Under 11 | $839K |
| Ibrance Palbociclib | 45 | 45 | Under 11 | $702K |
| Eliquis Apixaban | 45 | 45 | Under 11 | $26K |
| Gabapentin Generic | 40 | 63 | 12 | $344 |
| Revlimid Lenalidomide | 33 | 33 | Under 11 | $579K |
| Levothyroxine Sodium Generic | 31 | 58 | Under 11 | $166 |
| Jakafi Ruxolitinib Phosphate | 27 | 27 | Under 11 | $737K |
| Hydroxyurea Generic | 25 | 55 | Under 11 | $552 |
| Imatinib Mesylate Generic | 25 | 25 | Under 11 | $4,064 |
| Acyclovir Generic | 25 | 47 | Under 11 | $456 |
| Duloxetine Hcl Generic | 24 | 24 | Under 11 | $313 |
| Ondansetron Hcl Generic | 23 | 23 | 12 | $160 |
| Potassium Chloride Generic | 22 | 24 | Under 11 | $538 |
Brand drugs: - claims; generic drugs: 1,019 claims; opioid claims: 56.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Shantae L Lucas $814 ($814 in general payments such as food, travel and fees) from 20 companies. The largest payer was Novartis Pharmaceuticals Corporation with $155.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 6 | $155 |
| E.R. Squibb & Sons, L.L.C. BMY | 5 | $99.39 |
| Janssen Biotech, Inc. JNJ | 4 | $77.28 |
| AstraZeneca Pharmaceuticals LP AZN | 3 | $69.82 |
| Eisai Inc. 4523.T | 2 | $49.62 |
| Incyte Corporation INCY | 2 | $42.99 |
| Celgene Corporation BMY | 1 | $31.06 |
| Stemline Therapeutics Inc. | 1 | $29.78 |
| Daiichi Sankyo Inc. 4568.T | 1 | $28.09 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 1 | $27.15 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.